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ABSTRACT
Objective: Optimising uptake of colorectal cancer
(CRC) screening is important to achieve projected
health outcomes. Population-based screening by
flexible sigmoidoscopy (FS) was introduced in England
in 2013 (NHS Bowel scope screening). Little is known
about reactions to the invitation to participate in FS
screening, as offered within the context of the Bowel
scope programme. We aimed to investigate responses
to the screening invitation to inform understanding of
decision-making, particularly in relation to non-
participation in screening.
Design: Qualitative analysis of semistructured in-depth
interviews and written accounts.
Participants and setting: People from 31 general
practices in the North East and East of England invited
to attend FS screening as part of NHS Bowel scope
screening programme were sent invitations to take part
in the study. We purposively sampled interviewees to
ensure a range of accounts in terms of beliefs,
screening attendance, sex and geographical location.
Results: 20 screeners and 25 non-screeners were
interviewed. Written responses describing reasons for,
and circumstances surrounding, non-participation from
a further 28 non-screeners were included in the
analysis. Thematic analysis identified a range of
reactions to the screening invitation, decision-making
processes and barriers to participation. These include a
perceived or actual lack of need; inability to attend;
anxiety and fear about bowel preparation, procedures
or hospital; inability or reluctance to self-administer an
enema; beliefs about low susceptibility to bowel cancer
or treatment and understanding of harm and benefits.
The strength, rather than presence, of concerns about
the test and perceived need for reassurance were
important in the decision to participate for screeners
and non-screeners. Decision-making occurs within the
context of previous experiences and day-to-day life.
Conclusions: Understanding the reasons for non-
participation in FS screening can help inform strategies
to improve uptake and may be transferable to other
screening programmes.
INTRODUCTION
Colorectal cancer (CRC) screening is im-
portant in reducing CRC-related mortality.1–3
In England, a flexible sigmoidoscopy (FS)
test at 55 years has been added to the exist-
ing faecal occult blood testing (FOBT)
population-based CRC screening programme
offered between 60 and 74 years.4 Since
2013, the FS programme, termed Bowel
Strengths and limitations of this study
▪ Qualitative methods used within this study
allowed an in-depth exploration of the contexts,
decision-making processes and emotional reac-
tions rooted within the reasons provided for non-
participation in colorectal cancer screening.
▪ Our recruitment strategy allowed for anticipated
difficulties in recruiting non-screeners, however,
the overall response to our study invitation
remained low.
▪ Purposive sampling ensured that we were able to
include accounts from a full range of participants
in terms of their beliefs, decision-making and
attendance.
▪ Our sampling allowed us to compare a diverse
range of accounts from screeners and non-
screeners within and across research sites and
screening centres, including participants living in
the most deprived areas within the UK.
▪ Our sample did not include enough respondents
from ethnic minority groups to draw conclusions
about more specific cultural influences.
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scope, has been progressively implemented across the
UK through regional bowel screening centres. Each
centre covers a geographical population which is served
by a number of screening sites (endoscopy units). Each
centre is expected to have at least one site offering FS
screening by the end of 2016, with complete coverage of
the English population expected around 3 years after
that. The primary purpose of FS screening is to prevent
CRC by identifying and removing adenomas before they
develop malignant changes. It has been shown to
reduce CRC mortality and incidence in the UK,1 5
Europe and the USA.6 The effectiveness of any
population-based screening programme is reliant on
high uptake. At 43.1%, CRC screening uptake is lower
than breast or cervical cancer screening (even among
women),7 and uptake for FS is lower than that for
FOBT.4 8 Understanding the influences on decision-
making and non-participation in FS screening is there-
fore important to help optimise projected gains in mor-
tality and reduce health inequalities.
A number of sociodemographic, ethnic and socio-
logical influences on FOBT screening participation
have been identified.9–14 Intervention studies incorpor-
ating factors such as general practitioner (GP) endorse-
ment,15 reminders and social networks have shown
these can have a positive effect on uptake. However,
the evidence is inconsistent,16 17 and effectiveness is
likely to be, in part, influenced by the healthcare
context in which the intervention is based. The dynam-
ics of decision-making for FS screening may be quite
different, with its high technology, specialist-based
approach, a less proactive role required for participants
and a different method of invitation. Qualitative
research among participants in the UK FS Trial1 has
identified that most of the effects of demographic and
health variables on interest in participation are
mediated by sociocognitive variables,18 although actual
uptake among interested participants is influenced
more directly by demographics, health and stress.19
Non-participation is also reported to be influenced by
avoidant attitudes towards screening, other health
beliefs,20 21 fear22 and deprivation.23 This research has
been undertaken with people offered screening within
a research trial context or has focused on intention
rather than actual screening behaviour. A quantitative
analysis of screening uptake in the first 14 months of
the English Bowel scope screening programme identi-
fied independent effects of deprivation, gender and
screening centre on screening participation.7 We
sought to gain a more thorough understanding of the
influences on screening participation by conducting
an in-depth exploration of the responses of members
of the public to their invitation to the Bowel scope
screening programme. By taking this approach, we
obtained their reflections on their actual decision-
making and experiences, their awareness and under-
standing of CRC and the contexts surrounding reasons
for non-participation.
METHODS
Setting
The study took place across two research sites (the
North East England and East of England), chosen
because of their diverse deprivation profiles and their
location within areas covered by two of the first English
pilot NHS Bowel scope screening centres. The study was
provided a favourable ethical opinion by the NHS
Bromley NRES Committee (14/LO/0207).
Participant recruitment
For each general practice included in the screening pro-
gramme, the NHS CRC screening hubs generate a letter
inviting patients aged 55 years to attend for FS screening
at their local Bowel scope screening centre. Thirty-one
eligible general practices (18 North East England; 13
East of England) agreed to mail study information
explaining the aims of the study and a study sampling
questionnaire to all patients invited for FS screening
within the previous 6 months. The Bowel scope screen-
ing invitation process takes 8 weeks from initial contact
to appointment date, and no study information was sent
to patients during this time to avoid influencing their
decision-making. Recruitment took place between
March and December 2014.
Participants were asked to return the sampling ques-
tionnaire directly to the study researchers indicating
whether they wished to be contacted for a face-to-face
interview. The sampling questionnaire gathered infor-
mation on gender, ethnicity, screening attendance
and a series of items to assess attitudes towards
cancer, concerns about the FS test and current bowel
symptoms. This information was used to purposively
sample participants for interview, helping to ensure
we interviewed people who had attended FS screening
(screeners) and those who had not attended (non-
screeners), including people with a range of attitudes,
beliefs and reasons for attending and not attending
screening.
Study information was initially sent to 623 eligible
patients. There were lower rates of questionnaire return
among the non-screeners (36%) than the screeners
(61%). To adhere to the principles of qualitative purpos-
ive sampling,24 after 5 months of recruitment we only
sent recruitment material to non-screeners, thereby
helping to ensure we recruited from this typically hard
to reach group. At this stage, study information was
posted to a further 552 non-screeners in phases until we
had interviewed 25 non-screeners and 20 screeners and
no new themes were emerging from the participants’
accounts.
The sampling questionnaire included an open ques-
tion inviting written responses for reasons for non-
attendance. By interviewing people who had undergone
and not undergone screening, we were able to explore
similarities and differences in beliefs and decision-
making processes.
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Data collection
Semistructured, face-to-face interviews were undertaken
in the participant’s home by NH and LB, both experi-
enced postdoctoral qualitative researchers. Interviews
were preceded by an explanation of the research, a
reiteration that the researcher was not a member of the
FS screening team or the general practitioner (GP) prac-
tice. Written consent was obtained before the interview
started. The semistructured interview guide included
general open-ended questions on reasons for attending
or not-attending screening, concerns about FS screen-
ing, understanding of CRC and views on screening
within the NHS. Participant-initiated topics were encour-
aged and pursued during the interviews. Additional
interview prompts included knowledge, beliefs and pre-
vious experiences of cancer in general and cancer
screening more specifically; practicalities, concerns and
experiences associated with screening attendance and
bowel preparations and participation in other screening
programmes. Interviews lasted between 30 min and
50 min and were audio-recorded. All written responses
to an open-ended question included within the sam-
pling questionnaire (“please let us know below if there
were any other reasons or circumstances which meant
you were unable to, or did not wish to, take part in
Bowel scope screening”) were recorded for analysis.
Qualitative analysis
All interviews were transcribed verbatim. Interview tran-
scripts and written responses were analysed using the-
matic analysis.25 After familiarising themselves with the
data, NH and LB initially worked independently then
collaboratively to develop a data-driven coding frame-
work. Once data were organised into codes, using word
processing software, NH and LB searched for patterns
and developed early themes, exploring similarities and
differences between ‘screeners’ and ‘non-screeners’.
These themes were reviewed for credibility by referring
back to the empirical literature on screening behaviour.
Peer validation was sought through sharing with the
study steering group. This group comprised clinicians
and academics with expertise in screening research and
a service user, with experience of FS screening and an
interest in the bowel cancer screening programme.
RESULTS
We received a total of 214 sampling questionnaires (88
non-screeners; overall response rate 18%), 110 of whom
agreed to be contacted for interview (32 non-screeners).
Responses to the items on the sampling questionnaire
indicated that the majority of screeners and non-
screeners held positive beliefs about CRC screening
(screeners 100% n=126; non-screeners 98% n=86).
Many had concerns about the nature of the FS investiga-
tion (screeners 72% n=91; non-screeners 66% n=58).
Twenty-eight people who did not wish to be interviewed
returned written responses, and these data were analysed
thematically in conjunction with interview data. No sig-
nificant differences in responses to the items included
on the sampling questionnaire were identified between
those who agreed to be interviewed (n=104) and those
who did not (n=110). There were demographic differ-
ences between the recruitment areas with 71% of
respondents from the North East from areas within
the two highest quintiles of indices of multiple
deprivation in the UK compared with only 4% of
those from the East of England. Table 1 summarises
the numbers of responses received and numbers
of participants interviewed (screeners n=20; non-
screeners n=25). Online supplementary appendices
1 and 2 provide a summary of the beliefs and atti-
tudes of those interviewed towards screening along
with key facilitators or barriers to attendance at the
screening appointment.
Interview data and written comments demonstrated
considerable heterogeneity in reported reasons
for non-participation and multiple reasons were
common. These are summarised in figure 1 in rela-
tion to the stages of the programme invitation,
separating the reasons for unwillingness and inability
to be screened.
The following section describes further in-depth
exploration of the interview data in relation to the
contexts, decision-making processes and emotional
reactions rooted within the reasons provided for
non-participation. These centred primarily around the
balancing of concerns in relation to the FS test and a
potential cancer diagnosis, beliefs about the need for
reassurance, conflicting priorities and practical issues
in relation to appointment scheduling. We use case
examples (see box 1) as well as interview quotations to
illustrate the complexity of these processes and to
highlight some typical experiences of non-screeners in
relation to their non-participation.
Concerns and perceived risk: invasiveness,
embarrassment and potential harm
A general lack of awareness regarding the Bowel scope
programme due to the early stage of national implemen-
tation at the time of our study meant that most intervie-
wees with no prior experience or knowledge of
endoscopic procedures described having reacted to
their screening invitation with surprise or shock. The
decision not to participate in screening for some
had been based on a careful consideration of the per-
ceived risks and harms associated with the test (see case
study 1). The anticipated ‘unpleasantness’ of the FS
procedure associated with its ‘invasiveness’ and poten-
tial embarrassment for screeners and non-screeners
alike could however result in strong emotional reac-
tions to the invitation (see case study 2). The FS test
was described by some women as more intrusive and
embarrassing than breast or cervical cancer screening,
which were more easily normalised as part of being a
‘woman’.
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The information provided in the screening invitation
relating to potential harm and, in particular, bowel
puncture had caused additional concern and anxiety for
some interviewees.
I read the bit which stuck in my head that it could punc-
ture your bowel…and I thought oh right I’m not doing
that… I was just too scared to have it done. (D-60 female
non-screener)
The bowel preparation (enema) was also described as
a barrier. These concerns often only became apparent
after the initial decision to attend screening, as the
implications associated with the bowel preparation were
not always clearly understood until further down the
invitation process when the kit and instructions arrived
through the post:
The only reason I cancelled my appointment was
because after speaking to an assistant I realised I had to
apply the enema an hour before attendance,… I could
not do this at work. I would also feel worried about
driving to the hospital after applying an enema! (C-4
female non-screener)
Figure 1 Summary of reasons for non-participation in flexible sigmoidoscopy (FS) screening in relation to screening invitation
process.
Table 1 Summary of responses
Male
(East)
Female
(East)
Male
(North East)
Female
(North East) Total
Total questionnaire responses 55 70 34 55 214
Qualitative data totals 10 27 11 25 73
Written qualitative comments
(non-screeners)
2 11 4 11 28
In-depth interviews (non-screeners) 3 11 3 8 25
In-depth interviews (screeners) 5 5 4 6 20
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Consideration of outcomes: perceived need for
reassurance and likelihood of a potential cancer diagnosis
The anticipated unpleasantness of the procedures was
often outweighed by strong beliefs about the personal
need for reassurance offered by screening. It was the
strength of perceived need for reassurance, rather than
positive beliefs about the value of screening per se, that
was more likely to be related to a rapid and/or firm
decision to attend despite concerns about the proced-
ure. A commonly reported need to put up with the
inconvenience, embarrassment and unpleasantness of
the test was evident within the accounts of screeners and
the non-screeners who had wished to take part.
However, the need for reassurance could override even
intense anxiety about the procedure.
Panic. I didn’t fancy this thing in my bum, but you’ve got
to do it.… I’ve got to do this for my peace of mind. (C-39
male screener)
Similarly, a strong, and potentially legitimate, per-
ceived lack of need (eg, due to a recent endoscopic
investigation, see case study 3) was more likely to result
in a firm non-screening decision. While the majority of
interviewees, whether they had attended or not, held
positive attitudes towards population-based cancer
screening in principle and acknowledged the import-
ance of early diagnosis, decision-making was more likely
to be based on assessments of their own personal per-
ceived susceptibility to bowel cancer. For some people,
these beliefs were related to healthy behaviour choices
or the presence of symptoms:
I do not feel at risk of bowel disease because I am not a
heavy drinker, I hardly ever take pills and I have been
vegetarian for 25 years and have an excellent diet and
fitness regime, But I still think it’s a great idea to offer
this screening to people 55+. (D-63 female non-screener)
Box 1 Case examples
Typical case examples—non-screeners
Case example 1: Female non-screener (D-61)—decision not to
be screened made based on consideration of harms and benefits.
Eileen is a retired midwife/nurse who had lots of experience
working within the NHS and dealing with screening-related
issues. Her father died of bowel cancer years earlier, and she
described how he suffered for many years before he died. She
thought very carefully about her response to the screening invita-
tion and spoke to family members who encouraged her to attend,
before calling to cancel her appointment. She attends all other
cancer screening programmes and feels that her decision-making
process for Bowel scope was very different and more involved
than for other types of screenings. “The main thing that struck
me was the statistics, you know one in 300 might have cancer, I
though well I’m not having that shoved up my arse frankly for the
sake of that, you know they might perforate my bowel.” She
believes that finding bowel cancer early does not necessarily
mean that you won’t die from it and is not convinced that the
Bowel scope programme “can be remotely cost effective”.
Case example 2: Male non-screener (D-34)—believed it is a
good thing to do, but unable to overcome concerns about nature
of the investigation.
Brian lives in a shared flat. He was shocked at receiving the invita-
tion and initially assumed it was related to ongoing medical inves-
tigations for cancer. Once he realised this was not the case, he
still felt this was something he probably should do, as “they prob-
ably screen people for a reason.” He felt very anxious because of
the intrusive nature of the test and he talked to his mother,
daughter and friends at the pub about it. They all encouraged him
to take part. He also looked up further information about the pro-
cedure on the internet. After a long time deliberating, he decided
he would go ahead with the screening, “grudgingly, I was kind of
just thinking I would have it done.” He had not realised that he
needed to confirm his attendance and then received a letter
saying it had been cancelled. “At that point I thought relief to be
honest and I decided to just leave it.” He feels screening is a
good thing, especially at his age, but had never considered bowel
cancer before. His father has died of prostate cancer and Brian
feels he would be more in need of prostate cancer screening. “If
nothing else I did read about it and it’s opened my eyes to bowel
cancer, which I’d never thought about at all, so it probably did
some good.” He would encourage others to take part, but no
longer has any intention to himself.
Case example 3: Female non-screener (C-71)—Bowel scope
screening is currently unnecessary.
Barbara is retired and lives with her husband in a rural village.
Her invitation arrived just 6 weeks after she had undergone a sig-
moidoscopy following a GP referral for loose stools and rectal
bleeding. “I am very much of the opinion that people should be
responsible for their own health but to actually have the NHS just
sort of knocking on your door and saying we’d like you to test
this out for your peace of mind. I found it very welcome.” She
recently lost a close friend to bowel cancer and currently has two
other friends undergoing treatment for bowel cancer. After con-
tacting the help desk, she was advised FS was not required at the
moment, but she intends to take up the offer of screening before
her 60th birthday as she is aware from her friends that the signs
can be easily missed and she still has concerns “because of how
I am normally, it might be a little bit difficult for me to actually
isolate a change that’s abnormal.”
Case example 4: Female non-screener (D-44)—Desires to be
screened but unable to attend.
Rose is a full-time carer for her father and disabled daughter. She
has lost her mother and close relatives to bowel cancer and feels
concerned about her risks. She had a screening colonoscopy
5 years earlier and initially believed this was a repeat appointment.
When she realised everyone was being invited for screening, she
still wanted to take part. She was unable to attend her allocated
appointment time. She has called twice to reschedule, but is
unable to make an appointment far enough in advance to fit in
with her caring responsibilities. “I can only go on these certain
dates and they said well we can’t give you them dates because we
can only go up to a fortnight or so many days. I says well I can’t
do it then and I was a bit annoyed about that… I rang back and
they were filled up again, so I didn’t bother.” After that “I just
forgot, I’ve got that much going on, I just forgot, that’s all.” She
is still willing to undertake screening and thinks that she might
try again, but is aware she may potentially receive a further sur-
veillance appointment sometime in the future.
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Personal experience of any type of cancer, either their
own or of close others, seemed to heighten sensitivity to
the need for reassurance and the importance of ‘catch-
ing cancer early’ (see case study 4). On the other hand,
having witnessed suffering of a loved one after a long
period of cancer treatment or remission could enhance
fatalistic attitudes towards cancer.
Sometimes all these treatments and nothing works, so I
think I would just give in at the first hurdle… they
(friends with bowel cancer) went through all that battle
and nothing worked. (D-60 female non-screener)
A preference not to know the outcome of screening
was also described by those with existing physical and
mental health conditions, particularly when associated
with a reluctance to undergo treatment or a perceived
inability to cope with the demands of a cancer diagnosis.
Although there were some exceptions, most respon-
dents’ accounts described their understanding of FS
screening as a diagnostic tool rather than a preventive
measure.
Responsibilities
A common narrative in the interviews of screeners and
non-screeners was their sense of responsibility to take
advantage of the screening opportunity. For some this
included being accountable to the wider society, particu-
larly in respect of the use of public (NHS) funding and
resources, reporting an awareness that screening and
early cancer detection was more cost-effective than later
treatment and a responsibility to maintain their own
health. However, appropriate use of resources was also
described as a reason not to attend the Bowel scope
appointment.
I won’t have treatment for cancer… So, you know, I just
think I’m not wasting people’s, the NHS’s money or what-
ever, you know, I’m just not. (D-83 female non-screener)
Competing priorities and chaotic lives
Fitting in a screening appointment could be problematic
when people were living chaotic lives, perhaps in
deprived circumstances, caring for ill or disabled chil-
dren or parents, or were faced with conflicting demands
such as ill health. Difficulties attending a screening
appointment were exacerbated when there was a sense
of not having any reserves left to deal with potentially
negative outcomes, other more immediate health con-
cerns, or there were practical issues administering the
enema or getting to hospital. The experiences of
re-arranging inconvenient appointment times varied by
screening centres, but the appointment system was a
common barrier to many of those who had wished to
take part and were unable to (see case study 4).
Employment was another commonly reported compet-
ing priority. While appointments were in the evening
and at weekends, the need to request time off work to
attend could be a major barrier, even for those who
were positive about screening.
Decision-making and future intention
Although some interviewees reached a quick and firm
decision about screening, decision-making was often
described as a dynamic process and was more difficult
when dissonant beliefs were held about potential screen-
ing outcomes and the need for screening.
If they found something, how would I react to that? Well
I might be better off not knowing. But in the back of my
mind that’s saying yeah but it’s better to know early.
(C-112 female non-screener)
In these instances, decisions were reached with more
difficulty and could change more easily and more
frequently.
Many times I say no, I’m not going to do it, I don’t want
to have that in my body…one minute I was going yes,
other minute I was going no…it wasn’t an easy decision!
(C-39 male screener)
Seeking additional information and talking to others
was also more likely in these instances. Many non-
screeners reported that they would consider taking part
in screening in the future or had since decided to take
part in FOBT screening when offered after their sixtieth
birthday.
DISCUSSION
This is the first qualitative study that we are aware of to
explore the decision-making of people who have been
invited to attend FS screening when offered as an orga-
nised population-based programme. Our findings dem-
onstrate that FS screening offered within this context is
generally valued and associated with positive attitudes in
relation to the importance of early diagnosis of cancer.
These attitudes are held by those who do not attend
screening as well as those who do. Our in-depth explor-
ation of the contexts, decision-making processes and
emotional reactions rooted within the reasons provided
for non-participation showed that these centre primarily
around the balancing of concerns about the FS test and
potential cancer diagnosis, beliefs about the personal
need for screening and reassurance, conflicting prior-
ities and practical issues in relation to appointment
scheduling.
The potential of FS screening to remove precancerous
polyps, thereby allowing cancer prevention as well as
detection, was absent in many accounts from screeners
and non-screeners. When mentioned, this aspect of the
screening was rarely described as having had a major
influence on their decision-making. Our findings, never-
theless demonstrate that non-participation in FS screen-
ing is not necessarily due to a lack of knowledge,
unjustified concerns or the lack of intention to attend
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an appointment. Furthermore, some participants felt
their decision not to be screened was a rational and
informed choice within the context of their individual
circumstances.
One of the strengths of our research is that we were
able to compare a diverse range of accounts from
screeners and non-screeners within and across research
sites and screening centres, including from participants
living in the most deprived areas within the UK.
Although our recruitment strategy, based on experience
from a previous study,14 allowed for anticipated difficul-
ties in recruiting non-screeners, the overall response to
our study invitation was low. We were successful, none-
theless, in purposively sampling a diverse group of parti-
cipants in terms of their beliefs, decision-making and
reasons for non-attendance. We continued interviewing
until data saturation was reached that is, no new themes
were emerging from additional accounts. Our recruit-
ment methods were based on qualitative purposive sam-
pling.24 Further quantitative research would be required
to ascertain the frequency of the different identified
influences on decision-making within the wider popula-
tion. The strength of our findings, however, lies within
the in-depth exploration of the range of processes and
influences involved in screening behaviour that is pro-
vided by our analysis of the accounts of our participants.
Efforts were made to ensure that interviewees did not
feel judged about their non-attendance or coerced into
future screening decisions. Although a degree of post
hoc rationalisation is possible, our impression was that
participants provided open and honest accounts of their
experiences. Our sample did not include enough
respondents from ethnic minority groups to draw con-
clusions about more specific cultural influences,26 and
transferability of our findings to other regions and
screening programmes may be limited. Despite includ-
ing a mix of men and women and people from areas of
high and low deprivation, we were not able to identify
any influences specific to gender or deprivation. Further
focused analysis in this area may, however, be of benefit,
particularly as some of the barriers we identified includ-
ing caring responsibilities, work practices and health
benefits which are often gendered or socioculturally
determined.
Our study complements the findings of a previous
qualitative study of non-participation nested within in
the UK FS Trial,20 as we were able to include and
compare accounts of those with some intention to take
part in FS screening but who were unable to, those for
whom screening was not necessary and those who had
attended screening. In contrast to their findings that
practical barriers do not play a major role in screening
uptake, we found that barriers such as inability to attend
the screening appointment do play a role and that these
barriers have a greater influence on actual appointment
attendance than the initial decision or intention to
attend. An analysis of variation in uptake during the first
14 months of the Bowel scope screening programme7
identified that centre effects have an independent asso-
ciation with uptake along with deprivation and gender
and that those offered out of hours appointments were
more likely to attend screening. Our participants’
experiences and satisfaction with re-arranging inconveni-
ent appointment times differed between screening
centres. For some people, needing to request time off
work to attend an appointment was seen to be embarras-
sing and was not always an appropriate option. Our
study was completed in the early stages of the roll out of
the Bowel scope programme when population and
screening centre coverage was limited. Our findings
indicate, however, that facilitation of uptake and satisfac-
tion can be maximised by ensuring the flexibility of the
appointment scheduling processes and accommodating
those who would like to attend but are unable to when
initially invited. Non-screeners who were undecided or
unable to attend their initial invitation may benefit from
an additional reminder at a later date. The integration
of reminders into the screening programme has more
recently also been shown by others to potentially be a
feasible option worthy of further research.27 A more
in-depth quantitative analysis on screening uptake
including data on how many people confirm, reschedule
or cancel their appointment would be beneficial to
ascertain the portion of non-screeners who may benefit
from improved flexibility or a safety netting approach to
appointment rescheduling. Implications on programme
delivery would also need to be considered. At present,
Bowel scope clinic lists are ‘overbooked’ to accommo-
date non-attenders; a challenge for the programme is to
balance service efficiency against capacity to maximise
uptake while maintaining satisfaction with the appoint-
ment scheduling process and accommodating those who
would like to attend but were unable to when initially
invited.
Our findings confirm the importance of the influence
of the perceived burden of the FS test, identified by
others.8 12 20 28 These concerns were evident across most
participants, however, comparisons of accounts between
screeners and non-screeners showed that when there is a
strong perceived need for reassurance about potential
cancer presence, concerns about the invasiveness of the
test and other practical barriers were more readily over-
come. The concept of ‘perceived need for reassurance’,
as described in our analysis, reflects an appraisal
response to the activation of emotional reactions trig-
gered by the screening invitation, specifically in relation
to beliefs about personal risks and circumstances. Our
findings suggest that it is the strength of this perceived
need rather than its presence that seems to be a crucial
motivational driver of screening behaviour. It is directly
influenced by beliefs about perceived personal suscepti-
bility or vulnerability to cancer, coping style preferences,
emotions and outcome expectancies (including fear and
anxieties about the test itself, a potential cancer diagno-
sis and treatment), beliefs about screening and the
sociocultural context. ‘Perceived need for reassurance’
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therefore provides a useful lens through which to under-
stand the decision-making process, as it allows for the
involvement of a combination of existing sociopsycholo-
gical constructs from health behaviour theories that
have been used to explain and predict screening uptake,
such as the extended health belief model.29 Crucially,
‘perceived need for reassurance’ also allows for the
influence of emotion on behaviour and can be seen as
being inextricably tied to the appraisal and coping pro-
cesses that take place when faced with a health threat.30
The role of emotions and coping strategies in CRC
screening behaviour has been previously reported. A
questionnaire study of a subsample of the UK FS trial
participants, for example, concluded that finding
thoughts about cancer uncomfortable is associated with
lower screening uptake and that different aspects of
cancer fear can facilitate and inhibit screening intention
and behaviour in different ways.22 The accounts from
our participants illustrate and contextualise the strong
emotions that can result from receiving a screening invi-
tation associated with concerns not only about the
screening process, but also with a potential cancer diag-
nosis and outcome expectancies associated with treat-
ment beliefs and, for a small minority, general anxiety
associated with hospital attendance. Our analysis also,
therefore, complements findings by Oster et al31 that
people’s decisions to undergo CRC screening vary
according to their degree of ambivalence towards
finding out their cancer status and concurs with Palmer
et al32 who propose that people do not wish to know
the outcome of screening when they view treatment as
‘futile and unpleasant. Anticipated regret, the deci-
sion to take action to avoid experiencing unpleasant
emotions associated with not having acted in a par-
ticular way, is a more cognitive-based emotional influ-
ence on screening uptake that has been found to
have a complex relationship with CRC screening
behaviour in a recent intervention study on FOBT
screening,13 and this is reflected within our partici-
pants’ accounts as an influence on their motivation to
be screened.
The reported relationship between the lack of abdom-
inal symptoms and lower uptake of CRC screening8 28
can also be explained within the context of a lower per-
ceived need for reassurance. Perceived susceptibility or
vulnerability to a particular illness is an important
element of many theories used to explain health beha-
viours such as screening.18 20 When illness beliefs are
associated with a lower perceived susceptibility to cancer,
the motivation to be screened may not be strong
enough to overcome any associated concerns. Within
our participants’ accounts, this was linked to healthy life-
style choices as well as symptoms.
Our analysis demonstrates how decision-making pro-
cesses in relation to FS screening are firmly situated
within, and influenced by, the wider sociocultural context
of people’s lives, particularly in relation to their previous
experiences with, and/or family history of, cancer. In the
UK, uptake of CRC screening11 23 and more specifically
for FS4 7 33 is lower in areas of higher deprivation.
Further research is needed to explore the mediating
effects of factors associated with higher deprivation such
as existing physical and mental health problems (that
may affect the desire and/or ability to attend the screen-
ing appointment), the lack of desire for potential treat-
ment and lower flexibility in employment leave.
Difficulties assessing sociocultural norms around FS
screening behaviour were commonly alluded to in our
data, particularly for those with no prior experience or
knowledge of endoscopic procedures. As the Bowel scope
programme extends and awareness increases, ‘normalisa-
tion’ of FS screening may help to improve uptake32 and
positive experiences of the screening procedures will be
important in this regard. The importance of information
on how other people deal with particular situations has
been highlighted by others,34 and some participants sug-
gested that knowing about the screening experience of
others would have been helpful.
Cancer screening is often described in terms of a
responsible or moral choice.10 14 35 Our findings demon-
strate that the moral responsibility to ‘catch cancer early’ is
a common and often dominant narrative. Even when
present, however, these beliefs do not necessarily result in
screening uptake and in some instances, non-participation
in screening was also be explained in terms of moral
choices and responsibilities, particularly within the context
of wasting limited publically funded healthcare resources.
Finally, our analysis highlights the need to acknowledge
the dynamic nature of decision-making and screening
intention within future research. Intention is often mea-
sured and reported as a relatively stable factor, however,
our findings support a more variable stability of intention
which should be taken into account when interpreting
research findings in this area.
CONCLUSIONS
In-depth exploration of the contexts, decision-making
processes and emotional reactions rooted within the
reasons provided for non-participation highlight the
need to recognise the heterogeneity of non-screeners,
particularly in relation to whether they are unwilling or
unable to attend screening. Findings can inform the
development and evaluation of targeted interventions
and help to understand how psychosocial, provider and
healthcare delivery factors interact to influence screen-
ing behaviour.
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